🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It's #WorldCancerResearchDay! Let's keep working together to ensure a brighter future for all. Check out the #WCRD initiative's website here: worldcancerresearchday.com

Our CEO is fundraising for #CEOSleepout, Nov 10. Visit Simon's JustGiving page! #JustGiving justgiving.com/fundraising/si…

Our VP of Oncology, Allan Jordan, spoke with Gold about the promise and pitfalls of #AI in #drugdiscovery. #pharmaceuticalindustry #researchanddevelopment

hubs.la/Q01qF9ZN0 Just under 3 weeks until our CEO - Simon Hirst – takes part in the #ceosleepout! The Nottingham arm of this national charity event will see CEOs sleeping out at Meadow Lane Football ground to raise money for the homeless. Please donate if you can!

"The current thinking is that a third of cancers might be preventable, but I believe this is a significant understatement." The NHS's #Stoptober campaign is almost at an end, but it's never too late to quit smoking. Our VP of #Oncology shares his thoughts bit.ly/3gN2UsY

As members from our team prepare for #Neuroscience 2022 conference in San Diego, Dr. Max Mirza - our VP of Neuroscience - looks at the mission to help patients fight #neurodegenerativediseases. Read more on our blog: bit.ly/3DUycHs #sfn22 Society for Neuroscience (SfN)

Are you ready for #SfN22? Our neuroscience teammates are currently boarding their flights!✈️ What are you hoping to learn more about at Neuroscience 2022? #neuroscience #neuroscientists #drugdiscovery Society for Neuroscience Events

💙

Despite an intense #drugdiscovery effort, does the rising global incidence of #diabetes indicate a failure of the drug discovery process? Thanks to Steven - our Director of In-vivo pharmacology - for today's insights: lnkd.in/eQywMqgp #nailingdiabetes World Diabetes Day Diabetes UK

Thank you Drug Hunter for featuring Compound 27 CTPS1/2 in 'Small Molecules of the Month'! This was a collaboration between biotech Step Pharma and the drug discovery team at Sygnature Discovery. Read more here: bit.ly/3Z6S5Uh #drugdiscovery #biotech @drughuntersite

Fantastic for Sygnature Discovery to be partnering this programme which supports UK breakthroughs in #oncology. And for Jane Kendrew, our Director of Translational Oncology, to be on the Programme Faculty Panel. #ODP2 #drugresearch #innovation

Sygnature Discovery continues its expansion and investment by opening further dedicated laboratories at Alderley Park. This new space will provide increased capacity for up to an additional 130 scientists! #alderleypark #drugdiscovery #chemistry #medchem

On #WorldKidneyDay we're sharing 3 current trends in the field of kidney health and treatment: 🔵 AI & machine learning to identify new drug targets 🔵 In Vitro-In Vivo modelling 🔵 Novel solutions to improve kidney health Which do you think will make the biggest impact?

Best of luck to our team at the UK Retrosynthesis Competition!

What if you could rapidly assess the feasibility of a degrader project for your protein of interest? Welcome to CHARMED from Sygnature Discovery... 👉lnkd.in/e5eCMpxK #drugdiscovery #pharma #biotechnology

Sygnature Discovery's CEO, Simon Hirst, shares insights on finding the right start points and properties for success in targeted protein degradation. Learn about the CHARMED platform from Sygnature Discovery for rapid degrader assessment: lnkd.in/esQZKTFc #drugdiscovery

Join our Targeted Protein Degradation live webinar series on May 10th with Jamie Scott, Director of Medicinal Chemistry AstraZeneca. Register here to gain exclusive insights from expert drug hunters:info.sygnaturediscovery.com/targeted-prote…

Join us tomorrow with Jamie Scott, Director of Medicinal Chemistry at AstraZeneca as he describes two distinct approaches toward the degradation of Era (estrogen receptor alpha)  Register for the free live webinar here: lnkd.in/erccFa7h #medchem #drugdiscovery #biotech

Join Dr Roland Hjerpe and Dr Allan Jordan as they discuss hit generation and profiling strategies for targeted protein degradation (TPD) projects at a premium CRO. Don't miss this insightful webinar! Register now: lnkd.in/evhhqKCQ #TPD #SGL #degraders #drugdiscovery

Today, we are delighted to announce the acquisition of one of North America’s largest discovery Contract Research Organisations—Canada-based NuChem Sciences. Read the full press release (also available in French and Japanese): 👉info.sygnaturediscovery.com/a-new-discovery